The stromal reaction in pancreatic cancer creates a physical barrier that blocks therapeutic intervention and creates an immunosuppressive tumor microenvironment. The Rho/myocardin-related transcription factor (MRTF) pathway is implicated in the hyper-activation of fibroblasts in fibrotic diseases and the activation of pancreatic stellate cells. In this study we use CCG-222740, a small molecule, designed as a Rho/MRTF pathway inhibitor. This compound decreases the activation of stellate cells in vitro and in vivo, by reducing the levels of alpha smooth muscle actin (α-SMA) expression. CCG-222740 also modulates inflammatory components of the pancreas in KC mice (LSL-Kras; Pdx-1-Cre) stimulated with caerulein. It decreases the infiltration of macrophages and increases CD4 T cells and B cells. Analysis of the pancreatic adenocarcinoma (PDA) TCGA dataset revealed a correlation between elevated RhoA, RhoC and MRTF expression and decreased survival in PDA patients. Moreover, a MRTF signature is correlated with a Th2 cell signature in human PDA tumors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506531 | PMC |
| http://dx.doi.org/10.1038/s41598-019-43430-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade.
Int J Cancer
October 2024
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, USA.
Metastatic cutaneous melanoma is a fatal skin cancer. Resistance to targeted and immune therapies limits the benefits of current treatments. Identifying and adding anti-resistance agents to current treatment protocols can potentially improve clinical responses.
View Article and Find Full Text PDFInhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function.
Cells
February 2024
Donald W. Reynolds Department of Geriatrics and Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
RhoA-regulated gene transcription by serum response factor (SRF) and its transcriptional cofactor myocardin-related transcription factors (MRTFs) signaling pathway has emerged as a promising therapeutic target for pharmacological intervention in multiple diseases. Altered mitochondrial metabolism is one of the major hallmarks of cancer, therefore, this upregulation is a vulnerability that can be targeted with Rho/MRTF/SRF inhibitors. Recent advances identified a novel series of oxadiazole-thioether compounds that disrupt the SRF transcription, however, the direct molecular target of these compounds is unclear.
View Article and Find Full Text PDFHuman umbilical cord/placenta mesenchymal stem cell conditioned medium attenuates intestinal fibrosis in vivo and in vitro.
Stem Cell Res Ther
March 2024
Department of Gastroenterology, CHA Bundang Medical Center, CHA University School of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam, 13496, South Korea.
Article Synopsis
- - The study explores the potential of conditioned medium from human umbilical cord/placenta-derived mesenchymal stem cells (UC/PL-MSC-CM) as an anti-fibrotic treatment for inflammatory bowel disease, particularly focusing on intestinal fibrosis in both murine models and human cells.
- - Results showed that UC/PL-MSC-CM effectively reduced markers of fibrosis like procollagen1A1 and α-smooth muscle actin in both mice and human intestinal myofibroblasts, indicating a decrease in collagen deposition and improved intestinal structure after treatment.
- - The anti-fibrotic mechanisms involved the suppression of the Rho/MRTF/SRF signaling pathway, suggesting that UC/PL
Role of Rho/MRTF in Aggressive Vemurafenib-Resistant Murine Melanomas and Immune Checkpoint Upregulation.
Int J Mol Sci
September 2023
Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48823, USA.
Cutaneous melanoma is the deadliest skin cancer. Most have Ras-MAPK pathway (BRAF or NRAS) mutations and highly effective targeted therapies exist; however, they and immune therapies are limited by resistance, in part driven by small GTPase (Rho and Rac) activation. To facilitate preclinical studies of combination therapies to provide durable responses, we describe the first mouse melanoma lines resistant to BRAF inhibitors.
View Article and Find Full Text PDFInterplay of the transcription factor MRTF-A and matrix stiffness controls mammary acinar structure and protrusion formation.
Cell Commun Signal
October 2022
Institute for Physiological Chemistry, Medical Faculty, Martin Luther University Halle-Wittenberg, 06114, Halle (Saale), Germany.
Background: Ongoing differentiation processes characterize the mammary gland during sexual development and reproduction. In contrast, defective remodelling is assumed to be causal for breast tumorigenesis. We have shown recently that the myocardin-related transcription factor A (MRTF-A) is essential for forming regular hollow acinar structures.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!